Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 7, 2017

Primary Completion Date

January 30, 2019

Study Completion Date

February 1, 2019

Conditions
Small Intestinal Bacterial Overgrowth
Interventions
DIETARY_SUPPLEMENT

Novel Supplement Based Therapy

"Supplements and Dosage:~Detox Support: Liver-G.I. Detox BID for 30 days GI Support: L-Glutamine Powder 2 scoops QD for 35 days Microbial Balance: MicroDefense 1 capsule QD for 49 days Microbial Balance: A.C. Formula II 2 capsules BID for 49 days Probiotic: Probiotic-5 1 capsule QD for 49 days Digestive Enzymes: Digestive Enzymes Ultra with Betaine HCl As needed up to 6 longer term"

Trial Locations (1)

45056

Good Medicine, Oxford

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Dr. Nathan Morris, MD

UNKNOWN

collaborator

Genova Diagnostics

INDUSTRY

lead

Atrium Innovations

INDUSTRY

NCT03420976 - Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth | Biotech Hunter | Biotech Hunter